Nebula Research & Development LLC Abb Vie Inc. Transaction History
Nebula Research & Development LLC
- $1.17 Trillion
- Q2 2025
A detailed history of Nebula Research & Development LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 13,189 shares of ABBV stock, worth $3.07 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
13,189
Previous 19,581
32.64%
Holding current value
$3.07 Million
Previous $4.1 Billion
40.33%
% of portfolio
0.21%
Previous 0.38%
Shares
4 transactions
Others Institutions Holding ABBV
# of Institutions
4,298Shares Held
1.3BCall Options Held
16.1MPut Options Held
10.9M-
Vanguard Group Inc Valley Forge, PA177MShares$41.3 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$31.8 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$18.6 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$12.7 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.71 Billion0.52% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $412B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...